JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Osami Honjo
Christopher A. Caldarone
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oka, N.
Right arrow Articles by Caldarone, C. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Oka, N.
Right arrow Articles by Caldarone, C. A.
Related Collections
Right arrow Congenital - cyanotic
Right arrow Myocardial protection

J Thorac Cardiovasc Surg 2008;135:123-130
© 2008 The American Association for Thoracic Surgery


Cardiopulmonary Support and Physiology

Cyclosporine A prevents apoptosis-related mitochondrial dysfunction after neonatal cardioplegic arrest

Norihiko Oka, MD, Lixing Wang, MD, PhD, Wenyu Mi, MD, Wei Zhu, MD, Osami Honjo, MD, Christopher A. Caldarone, MD*

Division of Cardiovascular Surgery, the Hospital for Sick Children, University of Toronto, Ontario, Canada.

Received for publication March 16, 2007; revisions received April 27, 2007; accepted for publication May 2, 2007.

* Address for reprints: Christopher A. Caldarone, MD, Division of Cardiovascular Surgery, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada, M5G 1X8. (Email: christopher.caldarone{at}sickkids.ca).

Objective: Mitochondrial permeability transition pore opening plays a critical role in mediating the mitochondrial response to ischemia/reperfusion injury and initiation of apoptosis. We tested whether inhibition of mitochondrial permeability transition pore opening with cyclosporine A prevented apoptosis-related alterations in mitochondrial structure and function after cardioplegic arrest.

Methods: Newborn piglets (age ~14 days) underwent cardiopulmonary bypass, cardioplegic arrest (60 minutes), weaning from bypass, and 6-hour reperfusion. Comparison was made among cold crystalloid cardioplegia (n = 5), cold crystalloid cardioplegia with cyclosporine A pretreatment (n = 5), and noncardiopulmonary bypass (n = 5) groups.

Results: Early apoptosis signaling events (Bax translocation to the mitochondria) were prominent in cold crystalloid cardioplegia and prevented in cold crystalloid cardioplegia + cyclosporine A myocardium. Mitochondrial release of cytochrome c, determined by Western blot of cytosolic fractions and confocal quantitative colocalization analysis, was also prominent in cold crystalloid cardioplegia but prevented in cold crystalloid cardioplegia + cyclosporine A myocardium. Electron microscopy of isolated mitochondria demonstrated subjective alterations in mitochondrial architecture in cold crystalloid cardioplegia mitochondria, which were prevented by cyclosporine A. Deficiency of isolated mitochondrial oxygen consumption at Complex I was present in cold crystalloid cardioplegia mitochondria and prevented by cyclosporine A (P < .01). The frequency of deoxyuride-5'-triphosphate biotin nick end labeling-positive myocytes was diminished in cold crystalloid cardioplegia + cyclosporine A myocardium (P < .05). Mitochondrial resistance to calcium-mediated mitochondrial permeability transition pore opening was not different in cold crystalloid cardioplegia and noncardiopulmonary bypass mitochondria, suggesting that calcium overload is not solely responsible for the observed deficits in mitochondrial function.

Conclusions: Cyclosporine A pretreatment prevents postcardioplegia alterations in mitochondrial structure and function in a clinically relevant model of neonatal cardiac surgery. Prevention of mitochondrial permeability transition pore opening and apoptosis signaling events (Bax translocation and mitochondrial permeabilization) are associated with superior mitochondrial preservation.



Abbreviations and Acronyms CCP = cold crystalloid cardioplegia; COX IV = cytochrome c oxidase IV; CPB = cardiopulmonary bypass; CsA = cyclosporine A; Ig = immunoglobulin; IV = intravenous; MPTP = mitochondrial permeability transition pore; OCT = optimal cutting temperature; TUNEL = deoxyuride-5'-triphosphate biotin nick end labeling





This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
L. Wang, N. Oka, M. Tropak, J. Callahan, J. Lee, G. Wilson, A. Redington, and C. A. Caldarone
Remote ischemic preconditioning elaborates a transferable blood-borne effector that protects mitochondrial structure and function and preserves myocardial performance after neonatal cardioplegic arrest.
J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 335 - 342.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. Piot, P. Croisille, P. Staat, H. Thibault, G. Rioufol, N. Mewton, R. Elbelghiti, T. T. Cung, E. Bonnefoy, D. Angoulvant, et al.
Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction
N. Engl. J. Med., July 31, 2008; 359(5): 473 - 481.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. Oka, L. Wang, W. Mi, and C. A. Caldarone
Inhibition of mitochondrial remodeling by cyclosporine A preserves myocardial performance in a neonatal rabbit model of cardioplegic arrest
J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 585 - 593.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The American Association for Thoracic Surgery.